People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Pharmaceuticals, Biotechnology, Other Technology, Other, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Leafline Labs, LLC | — | Pharmaceuticals | Series A | $27.5M | $4.6M | 2014 |
| Steep Hill, Inc. | — | Biotechnology | Series A | $10.1M | $144.6M | 2018 |
| Simplifya Holdings, Inc. | — | Other Technology | Series A | $7.5M | $3.2M | 2021 |
| Frontier Financial Group, Inc. | — | Other | Seed | $4.7M | $40.0M | 2016 |
| VividGro, Inc. | — | Other Technology | Seed | $2.4M | $81.8M | 2018 |
| Agricare LLC | — | Manufacturing | Seed | $2.0M | $24.5M | 2014 |
| Peak Harvest Health, LLC | — | Manufacturing | Seed | $1.8M | $22.3M | 2014 |
| Hudson Health Extracts, LLC | — | Manufacturing | Seed | $1.1M | $13.3M | 2015 |
Mitchell Baruchowitz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mitchell Baruchowitz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ethan Ruby | 4 | 6 |
| Christopher Weidling | 2 | 2 |
| David Friedman | 1 | 9 |
| Alain Bankier | 1 | 7 |
| Colin Kelley | 1 | 4 |
| Gary Starr | 1 | 4 |
| Adam Schwartz | 1 | 4 |
| Abraham Morris | 1 | 3 |
| Mark Bachman | 1 | 3 |
| Scott Sozio | 1 | 3 |
| David Lampach | 1 | 2 |
| Stephen DeAngelo | 1 | 2 |
| David Quigley | 1 | 2 |
| Khim Lee | 1 | 2 |
| Marion Mariathasan | 1 | 2 |
| ANDREW BACHMAN | 1 | 2 |
| Mitchell Kulick | 1 | 2 |
| Bryan Lee | 1 | 2 |
| Joel Haney | 1 | 2 |
| Nigel Stobart | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.